US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class II · Moderate risk Ongoing

Praziquantel 56.8mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-775-2013
Class II · Moderate risk Ongoing

Potassium Phosphate Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-774-2013
Class II · Moderate risk Ongoing

Polidocanol

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-773-2013
Class II · Moderate risk Ongoing

Phenylephrine 1 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-772-2013
Class II · Moderate risk Ongoing

Phenylbutazone 200 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-771-2013
Class II · Moderate risk Ongoing

Phentolamine 20 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-770-2013
Class II · Moderate risk Ongoing

Phenobarbital 62. 5mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-769-2013
Class II · Moderate risk Ongoing

Pentosan 250 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-768-2013
Class II · Moderate risk Ongoing

Pento-Gluc 200 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-767-2013
Class II · Moderate risk Ongoing

PEN-DEX-CHLOR Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-766-2013
Class II · Moderate risk Ongoing

Papaverine 40 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-765-2013
Class II · Moderate risk Ongoing

Oxytocin 20 units/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-764-2013
Class II · Moderate risk Ongoing

Neomycin / Polymyxin / Dexamethasone Ophthalmic Drops

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-763-2013
Class II · Moderate risk Ongoing

Naproxen 100 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-762-2013
Class II · Moderate risk Ongoing

Miconazole 3% Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-761-2013
Class II · Moderate risk Ongoing

Micc

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-760-2013
Class II · Moderate risk Ongoing

Metoclopramide 5 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-759-2013
Class II · Moderate risk Ongoing

Methylprednisolone Acetate 80 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-758-2013
Class II · Moderate risk Ongoing

Methylcobalamin 25 mg/ml Inj and 5000 mcg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-757-2013
Class II · Moderate risk Ongoing

Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-756-2013
Class II · Moderate risk Ongoing

Metabolase Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-754-2013
Class II · Moderate risk Ongoing

Metabolase Forte Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-753-2013
Class II · Moderate risk Ongoing

Meloxicam 5 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-752-2013
Class II · Moderate risk Ongoing

Medroxyprogesterone 150 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-751-013